Evolving Frontiers in Systemic Lupus Erythematosus: Bridging Pathophysiology and Practice

Published Date: 06 Jul 2026

Evolving Frontiers in Systemic Lupus Erythematosus: Bridging Pathophysiology and Practice

Read Full News

Latest News

Pulmonary Fibrosis Video Diaries: Patient Experiences and Timely Recognition of PPF

Pulmonary Fibrosis Video Diaries: Patient Experiences and Timely Recognition of PPF

Acute Muscle Weakness and Skin Rash Following a Lupus Diagnosis

Clinicians consider many differentials

Optimizing the Diagnosis and Care of Sjögren's Disease: Real-World Perspectives From Patients and Clinicians

Optimizing the Diagnosis and Care of Sjögren's Disease: Real-World Perspectives From Patients and Clinicians

Competition Builds for Novel IgA Nephropathy Approach

Second agent targeting BAFF and APRIL appears effective in phase III trial

Care for Adults with Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Care for Adults with Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Pictorial Tool Helps Lupus Patients Stay on Hydroxychloroquine

Decision aid clarifies benefits and risks; trial shows it improved adherence

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Latest News

Pulmonary Fibrosis Video Diaries: Patient Experiences and Timely Recognition of PPF

Clinicians consider many differentials

Optimizing the Diagnosis and Care of Sjögren's Disease: Real-World Perspectives From Patients and Clinicians

Second agent targeting BAFF and APRIL appears effective in phase III trial

Care for Adults with Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Decision aid clarifies benefits and risks; trial shows it improved adherence

News All Time

HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503

Examining Disease Processes in Pulmonary Fibrosis and Mechanisms of Action of Novel Targeted Treatments: An Interactive 3D Animation

Examining Disease Processes in Pulmonary Fibrosis and Mechanisms of Action of Novel Targeted Treatments: An Interactive 3D Animation
HTTP error: 503HTTP error: 503HTTP error: 503

Next-Gen Therapies for gMG: The Science and Support for FcRn Antagonists

Next-Gen Therapies for gMG: The Science and Support for FcRn Antagonists
HTTP error: 503HTTP error: 503HTTP error: 503

Phone Data May Give Early Warning on Rheumatoid Arthritis Flares

Devices can record subtle behavioral changes before patients notice anything amiss
HTTP error: 503

Which Fibromyalgia Drug Offers the Best Value?

Modeling study supports an FDA-approved product over off-label amitriptyline

Recommended News For You

Recommended Articles For You

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot